Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22cisplatin%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22cisplatin%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22cisplatin%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (337)
1
Prevention of nephrotoxicity after high dose cisplatin administration in head and neck cancer patients receiving concurrent chemoradiation by adding oral rehydration solution to short hydration regimen: a randomized open label controlled trial. : Prevention of nephrotoxicity after high dose cisplatin administration in head and neck cancer patients receiving concurrent chemoradiation by adding oral rehydration solution to short hydration regimen: a randomized open label controlled trial.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Equivalency study of novel current standard 3-drugs combination regimen (ondansetron, dexamethasone and olanzapine) to netupitant containing regimen for preventing high dose cisplatin induce nausea and vomiting treatment, double blind placebo control trial : Equivalency study of novel current standard 3-drugs combination regimen (ondansetron, dexamethasone and olanzapine) to netupitant containing regimen for preventing high dose cisplatin induce nausea and vomiting treatment, double blind placebo control
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Efficacy of Short Hydration for Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatient : Efficacy of Short Hydration for Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatient
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Same-Patient Comparison of Fosaprepitant and Ondansetron in the Prevention of Chemotherapy Induced Nausea and Vomiting in Head and Neck Cancer Patients : A Same-Patient Comparison of Fosaprepitant and Ondansetron in the Prevention of Chemotherapy Induced Nausea and Vomiting in Head and Neck Cancer Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Phase II single-arm study of Trastuzumab combination with Cisplatin and Gemcitabine as first-line therapy in the HER-2 positive Advanced CholangioCArcinoma : Phase II single-arm study of Trastuzumab combination with Cisplatin and Gemcitabine as first-line therapy in the HER-2 positive Advanced CholangioCArcinoma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Prevention of nephrotoxicity after high dose cisplatin administration in head and neck cancer patients receiving concurrent chemoradiation by adding oral rehydration solution to short hydration regimen: a randomized open label controlled trial. : Prevention of nephrotoxicity after high dose cisplatin administration in head and neck cancer patients receiving concurrent chemoradiation by adding oral rehydration solution to short hydration regimen: a randomized open label controlled trial.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Equivalency study of novel current standard 3-drugs combination regimen (ondansetron, dexamethasone and olanzapine) to netupitant containing regimen for preventing high dose cisplatin induce nausea and vomiting treatment, double blind placebo control trial : Equivalency study of novel current standard 3-drugs combination regimen (ondansetron, dexamethasone and olanzapine) to netupitant containing regimen for preventing high dose cisplatin induce nausea and vomiting treatment, double blind placebo control
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Efficacy of Short Hydration for Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatient : Efficacy of Short Hydration for Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatient
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A Same-Patient Comparison of Fosaprepitant and Ondansetron in the Prevention of Chemotherapy Induced Nausea and Vomiting in Head and Neck Cancer Patients : A Same-Patient Comparison of Fosaprepitant and Ondansetron in the Prevention of Chemotherapy Induced Nausea and Vomiting in Head and Neck Cancer Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Phase II single-arm study of Trastuzumab combination with Cisplatin and Gemcitabine as first-line therapy in the HER-2 positive Advanced CholangioCArcinoma : Phase II single-arm study of Trastuzumab combination with Cisplatin and Gemcitabine as first-line therapy in the HER-2 positive Advanced CholangioCArcinoma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[34]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
337
Aufsätze
337
E-Artikel
337
E-Ressourcen
Zeitschriftentitel
316
WHO International Clinical Trials Registry Plat...
21
ClinicalTrials.gov
Thema
337
610
325
Study Type: Interventional
178
Recruitment Status: Not yet recruiting
83
Phase: Phase 2
80
Recruitment Status: Authorised-recruitment may ...
61
Phase: Phase 3
32
Recruitment Status: Recruiting
21
Recruitment Status: Completed
16
Phase: Phase 2/Phase 3
14
Medical Condition: Prevention of Chemotherapy-I...
12
Recruitment Status: Complete: follow-up complete
9
Phase: Phase 4
9
Study Type: Observational
8
Medical Condition: Male or female, 18 years or ...
6
Medical Condition: Nausea and vomiting in cance...
6
Medical Condition: The trial concerns patients ...
6
Medical Condition: The trial concerns patients ...
6
Phase: Phase 1
5
Hearing Loss
5
Recruitment Status: Unknown status
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
152
2020-
184
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
319
Englisch
12
Unbestimmt
6
Französisch
Haven't found what you're looking for?
Wird geladen...